Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study by Laura Scholz, MD, Florian Posch, MD, PhD, Eduard Schulz, MD, PhD, Max Gornicec, MD, Albert Wölfler, MD, Alexander C. Reisinger, MD, PhD, Andreas Reinisch, MD, PhD, Philipp Eller, MD, Florian Eisner, MD, Philipp Kreuzer, MD, Martin Stradner, MD, Alexander R. Rosenkranz, MD, Florian Krammer, PhD, Gernot Schilcher, MD, Robert Krause, MD, Stefan Hatzl, MD, PhD

Get full text